Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWhen you start Mounjaro (tirzepatide), the first few weeks feel different for almost everyone. The medicine begins working from your first injection, but visible weight loss usually takes several weeks to build, while your body adjusts to a new hunger rhythm. This is a prescription-only medicine; a clinician assesses whether it is right for you before any treatment begins. Here is what the evidence and clinical experience actually tell you about those early weeks, without the vague reassurances.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The first pen you receive contains four 2.5 mg doses, one per week. That dose exists to settle your system, not to deliver the full therapeutic effect. Its job is to let your gut and brain get used to a medicine that slows stomach emptying and shifts the hormonal signals around hunger and fullness. Expecting dramatic weight loss in week one sets you up for disappointment. Most people report that their appetite feels slightly different (meals feel filling sooner, the urge to snack quietens a little) but the scale may not move much yet. That is completely normal.
Your prescriber determines when to move to 5 mg (typically after four weeks) and each subsequent step up from there, based on how you are tolerating the current dose and your progress. No one should be adjusting their own dose or timing; the schedule is a clinical decision, not a personal preference. The NHS tirzepatide information page has a clear plain-English summary of how the medicine works if you want more background before your consultation.
One practical note: your first box arrives by DPD the next working day in plain, unbranded packaging. If you would like a fuller picture of what to expect when taking Mounjaro, including how the pen works and what the early weeks typically feel like, we have put together a dedicated guide covering the experience from the start. Store it in the fridge as soon as it arrives.
Gastrointestinal effects are the most frequently reported in the early weeks: nausea is the most common, followed by constipation, loose stools, indigestion and occasional burping. Fatigue and mild headache appear for some people too. These effects tend to be worst in the first day or two after an injection and improve as the week goes on. Many people find they have largely settled by the end of the first four-week pen, or once they have been on a given dose for a couple of weeks.
Severity varies considerably. Some people get through the early weeks with barely any disruption; others find the nausea genuinely uncomfortable for a short period. Eating smaller portions, avoiding very fatty or rich foods, and staying well hydrated all tend to help. The NHS England guidance on weight-management injections covers practical lifestyle measures you can take alongside treatment to reduce early side-effect burden.
Serious side effects are uncommon but worth knowing about. Severe, persistent stomach pain that radiates to the back could indicate pancreatitis, an infrequent but potentially serious reaction that warranted a specific MHRA Drug Safety Update in January 2026. If you experience that pattern of pain, seek urgent medical attention. Any suspected side effects can also be reported through the MHRA Yellow Card scheme.
Appetite reduction is usually the first thing people notice, and it is the mechanism through which weight loss follows. Once your body is eating meaningfully less without feeling deprived, the scale begins to move. Our guide on Mounjaro and what to expect walks through how appetite changes and weight loss tend to unfold across the early months, which many people find reassuring to read before they begin. The trajectory typically steepens as doses increase over the following months.
The long-term trial data gives a useful reference point. In SURMOUNT-1, adults taking tirzepatide for 72 weeks at the 15 mg maintenance dose lost an average of around 20–21% of their starting body weight. Those results came alongside a reduced-calorie diet and increased physical activity, which remain part of the licensed treatment plan. That is the realistic ceiling at maximum dose for people who tolerate it well, not a figure to expect in month one. If you want more detail on how results typically unfold over time, the page on how long Mounjaro takes to work goes into the evidence in more depth.
For context on how Mounjaro compares with the wider range of weight-loss treatments, the treatment overview sets out the options clearly. And if you are thinking about what private treatment typically costs, an honest breakdown of what is included in any legitimate price is on the Mounjaro cost context page.
The medicine changes your appetite signals; it does not change what your body needs. In the early weeks, when nausea can suppress eating significantly, protein intake and hydration deserve particular attention. Many people on GLP-1 and dual-agonist medicines eat considerably less than usual in the first month (which is part of the point) but muscle mass is worth protecting. Prioritising protein at each smaller meal, keeping water intake steady, and not skipping meals entirely are all things our prescribers mention regularly.
Physical activity does not need to be dramatic. Walking, gentle strength work, whatever suits you, the goal is to preserve lean tissue as weight falls. Your prescriber and, where relevant, a dietitian are the right people to tailor this to your situation; the general guidance here is not a substitute for a personal plan. If you have questions after your first injection and want to know more about the transition into the second week specifically, our guide on what to expect on week 2 of Mounjaro covers what commonly changes and what to watch for as the dose begins to settle. If you have questions after starting, our clinical team is available seven days a week, the contact page has the details, and aftercare is included as standard, with no additional charge.
If you are weighing up whether Mounjaro is the right fit for your circumstances before committing, the full Mounjaro treatment page covers eligibility, the clinical assessment process and how a private prescription route works. The prescribers at our clinical team review every consultation personally.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.